TGFB1 and graft versus host disease: Notably, there are further limitations, including T-cell dysfunction, cellular toxicity, resistance to transforming growth factor-beta (TGF-β), risks of graft-versus-host disease (GvHD), cytokine release syndrome (CRS), restricted migration, and limited tumor infiltration [31,32,33].